Tradestie Institutional Equity Comparison Engine

XNCR vs RGNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XNCR Overall Edge

XNCR Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xencor, Inc. (XNCR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, XNCR trades at 68.0x Forward P/E with -72.7% operating margin (+454.9% YoY revenue) versus RGNX at N/M Forward P/E and -120.4% operating margin (-69.2% YoY). In options structure, XNCR sits in BREAKOUT (10th %ile IV; Dealer Gamma Walls on Pro) against RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner XNCR
XNCR 68.0x vs RGNX N/M Fwd P/E
Growth & Margin Winner XNCR
Op Margin -72.7% vs -120.4% ยท YoY +454.9% vs -69.2%
Momentum & Technical Winner XNCR
1Y +154.5% vs -36.0% ยท 52W Pos 84% vs 19%
Options & Structure Winner XNCR
BREAKOUT (10th %ile IV) vs BREAKDOWN (52nd %ile IV)
XNCR NASDAQ
Xencor, Inc.
Pharmaceutical Preparations
$35.61
-3.99% 1D
Market Cap $2.9B
1M Return +55.84%
1Y Return +154.54%
Forward P/E 68.0x
Unified AI Score
29.6 / 100 SELL
Tech 50.0 Fund 32.0 Flow 66.0 Mom 40.0
RGNX NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.45
-2.49% 1D
Market Cap $500.9M
1M Return +7.58%
1Y Return -36.0%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 36.0 Fund 44.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XNCR +154.54% RGNX -36.0% Spread: +190.54 pp (XNCR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period XNCR Revenue RGNX Revenue XNCR Op. Margin RGNX Op. Margin Margin Edge
FY2018 $40M $220M -195.5% 40.3% RGNX
FY2019 $160M $40M 8.8% -422.9% XNCR
FY2020 $120M $150M -62.6% -77.1% XNCR
FY2021 $280M $470M 15.9% 34.0% RGNX
FY2022 $160M $110M -50.1% -233.2% XNCR
FY2023 $170M $90M -75.8% -297.1% XNCR
FY2024 $110M $80M -161.5% -280.0% XNCR
FY2025 $130M $170M -141.4% -94.6% RGNX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XNCR (8) vs RGNX (2)
Institutional Metric XNCR RGNX Criterion Row Winner
Market Capitalization Scale $2.9B $500.9M Larger Scale XNCR
Trailing P/E Ratio Valuation 68.0x N/M Lower Multiple XNCR
Forward P/E Ratio Valuation 68.0x N/M Lower Multiple XNCR
Revenue Growth (YoY) Growth +454.9% -69.2% Higher Growth XNCR
Operating Margin (TTM) Profitability -72.7% -120.4% Higher Margin XNCR
Net Profit Margin Profitability -58.8% -113.9% Higher Margin XNCR
Return on Equity (ROE) Capital Efficiency -19.9% -113.2% Higher ROE XNCR
52-Week Range Position Momentum 84% ($10โ€“$41) 19% ($5โ€“$16) Stronger Trend XNCR
Beta / 30D Volatility Risk Regime 1.21ฮฒ ยท 87% Vol 1.82ฮฒ ยท 76% Vol Lower Realized Risk RGNX
Unified Institutional Score Composite Signal 29.6 / 100 (SELL) 45.3 / 100 (HOLD) Higher Composite RGNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XNCR vs RGNX Buy Guide
XNCR BREAKOUT
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live XNCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RGNX BREAKDOWN
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RGNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XNCR nor RGNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.